Tango Therapeutics, Inc. short interest in 2024
In 2024, Tango Therapeutics, Inc.'s disclosed short interest ran from 11.82% of shares outstanding on 12 Jan 2024 to 6.98% on 31 Dec 2024, a change of -4.84 percentage points. The year's high was 11.87% on 31 Jan 2024 and its low 6.62% on 15 Nov 2024, averaging 9.14% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.70 days on 30 Apr 2024. Full history: Tango Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 11.82% (12 Jan 2024)
- End of year
- 6.98% (31 Dec 2024)
- Change
- -4.84 pp
- High
- 11.87% (31 Jan 2024)
- Low
- 6.62% (15 Nov 2024)
- Average
- 9.14%
- Highest days to cover
- 24.70 (30 Apr 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 11.82% | 18.80 | |
| 31 Jan 2024 | 11.87% | 12.15 | |
| 15 Feb 2024 | 10.83% | 16.80 | results (8-K) |
| 29 Feb 2024 | 10.02% | 17.63 | |
| 15 Mar 2024 | 8.33% | 10.68 | |
| 28 Mar 2024 | 9.55% | 15.18 | 10-K filed, results (8-K) |
| 15 Apr 2024 | 9.96% | 18.54 | |
| 30 Apr 2024 | 10.20% | 24.70 | |
| 15 May 2024 | 9.95% | 19.95 | 10-Q filed, results (8-K) |
| 31 May 2024 | 9.82% | 16.75 | |
| 14 Jun 2024 | 9.19% | 15.81 | |
| 28 Jun 2024 | 7.81% | 6.93 | |
| 15 Jul 2024 | 7.96% | 14.53 | |
| 31 Jul 2024 | 8.55% | 9.84 | |
| 15 Aug 2024 | 9.44% | 18.36 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 9.53% | 15.92 | |
| 13 Sep 2024 | 9.75% | 7.59 | |
| 30 Sep 2024 | 10.09% | 8.68 | |
| 15 Oct 2024 | 8.31% | 11.55 | |
| 31 Oct 2024 | 8.48% | 7.95 | |
| 15 Nov 2024 | 6.62% | 1.43 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 6.72% | 4.66 | |
| 13 Dec 2024 | 7.51% | 6.13 | |
| 31 Dec 2024 | 6.98% | 5.26 |
See also: Tango Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.